Podcasts about Drug

Investigative journalist Mariana van Zeller joins Bobby to break down what it really takes to gain the trust of cartels operating in and around the U.S. and why no story is ever worth a life. She shares what she’s learned embedding with traffickers, how drugs move through America, and why the crisis isn’t just criminal, it's public health. They also dive into the psychology of scammers, from international fraud rings to headline-making con artists, and debate whether the people behind these crimes see themselves as villains at all. It’s a conversation about power, opportunism, corruption, and the uncomfortable truth about America’s role in fueling it all. Watch The BobbyCast on Netflix! Follow on Instagram: @TheBobbyCast Follow on TikTok: @TheBobbyCast See omnystudio.com/listener for privacy information.

The Kouri Richins trial brings Carmen Lauber, Former Richins' Housekeeper, to the stand in this segment.The Kouri Richins murder trial continues in Utah as the state prosecutes the children's book author for allegedly poisoning her husband Eric Richins with fentanyl. Prosecutors allege she killed him for insurance money after secretly increasing his policy to $1.9 million. The defense maintains Eric died from accidental drug use.True Crime Today delivers real-time trial coverage as it happens—key testimony, critical cross-examinations, and the moments that matter. No waiting for nightly recaps. Watch the case unfold live.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#KouriRichins #KouriRichinsTrial #TrueCrimeToday #LiveTrial #EricRichins #UtahCourt #TrueCrimeNews #CourtTV #TrialWatch #BreakingCrime

This interview is disseminated on behalf of GT Biopharma. GT Biopharma (NASDAQ: GTBP) recently received approval from the U.S. Food and Drug Administration (FDA) for a new investigational drug trial for the solid tumor cancer treatment GTB-3650, as the race to develop a cure for cancer intensifies and the solid tumor market grows to $362 billion.Executive Chairman and Chief Executive Officer Michael Breen shares more details about the company's expectations and success indicators for the basket trial of the new medication, as well as upcoming milestones for 2026.Explore GT Biopharma: https://www.gtbiopharma.com/Watch the full YouTube interview here: https://youtu.be/VtISaFICJ5gAnd follow us to stay updated: https://www.youtube.com/GlobalOneMedia

Hey, first! We’re looking for your help. Can you take a couple minutes and fill out our Audience Survey? We’re dying to know more about the community that’s using this show — and about what’s working for you and what you’d like to see. Let us know! Today we’re switching it up. We’re sharing an episode from the new podcast Drug Story. In each episode, science journalist and self-described “public health nerd” Thomas Goetz goes deep on the story of a single drug — what it treats, how it came to be, and what it reveals about the business of health and disease. On this episode: the EpiPen, a device you’ll find in classrooms, on airplanes, in glove compartments — basically everywhere — because the EpiPen can be a literal life-saver for people with severe allergies. And of course, the EpiPen is also one of the most infamous examples of pharmaceutical profiteering gone bananas. That part of the story makes us especially geeked to share this episode. And there are more threads here — on the drug’s discovery, on the science of severe food allergies, and on what researchers have learned about preventing them — that Goetz does a great job of weaving together. If you like it, new episodes of Drug Story come out every week. We’ll be back with more Arm and a Leg in a few weeks. Meanwhile, don’t forget to help us by filling out our quick survey. Here’s a transcript of this episode. Send your stories and questions. Or call 724 ARM-N-LEG. Of course we’d love for you to support this show.See omnystudio.com/listener for privacy information.

Let us chat about today the inches all around us and also about how there is no market in healthcare all at once in this show. Today I am talking with Ivana Krajcinovic. And let me give you some examples of the inches. Two members of a plan get infusions at a hospital. And if these two members had gone down the street to get their infusions, the total cost of the two of them would have been $1 million less … $1 million less! How many inches is a million dollars? For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Or the examples Ivana Krajcinovic talks about coming up where an independent practice was charging $135 for a chemo infusion and the hospital down the street was charging for the same exact drug, by the way—the same exact infusion—$13,560 … $135 versus $13,560! We talk about affordability in this country? Member's paying coinsurance off that 13K, by the way. And if you're doing the math at home, that is a 10,000% markup. Or if we start from the Medicare price, it was a 40,000% markup. Then there's another example that Ivana talks about where a plan member went to a hospital and got a $90,000 bill for a series of infusions that, again, down the street would have been $185—all in. Inches much? So, it's pretty clear why the show is part of "The Inches Are All Around Us" series. Why do I say this is part of the "No Market" series? Because look, functioning markets rationalize prices. That's just what they do. So, if you have two places in the exact same geography and one of them is charging 500 times or whatever the other one, you don't have a market if they're both still in business a year later. Ongoing wild price variations is a big tell that there's no market to be had. Another tell, though, is that carrier networks, who are supposed to be the demand curve here—or at least that's what their marketing says or what we are all kind of led to believe—they advertise as high-value networks, right? The fact that any given network experiences essentially no business repercussions for spending a million dollars extra of its plan sponsors' (its customers') money—because that's who's paying for this, the self-insured employer or union, at the end of the day—and the network, the carrier network doesn't lose business as a result … Right? Listen to the show from last week with Jacob Asher, MD (Take Two: EP398) about the carrier nonmarket and why this is the case. But bottom line, if anyone is waiting on a market to constrain prices for them, that is very magical thinking. Where this whole thing is gonna wind up, by the way, is with my guest today, Ivana Krajcinovic, suggesting a roadmap to make a whole lot more likely that you'll pay $135 for an infusion instead of 13 grand. For more on this, do go back and listen to the show with Keith Hartman, RPh, by the way. We teed this off a couple of years ago. That was episode 369. But in Ivana's upcoming roadmap that you're gonna hear about (just doubling down on the spoilers—if I'm gonna do something, I might as well do it well), but in that roadmap, direct contracts with indie practices will feature a starring role. I'm telling you this because if you're one of those folks that listens to like 23 minutes of any given podcast and then bails, make sure you make it to around the 30-minute mark of the show. As I have said several times already, my guest today is the incomparable Ivana Krajcinovic, the outgoing vice president of healthcare delivery at UNITE HERE HEALTH. Ivana has just retired, but she spent over three decades with her team protecting the health and the hard-earned wages of 230,000 hospitality workers. She is exactly the kind of "dangerous expert" that we love to have on the show—someone with the wisdom about how the system actually works and the articulate willingness to talk about it. Okay … so, this conversation about the inches and the nonmarket for infusions specifically in this country, for more information, do go back and read the really excellent Bloomberg News exposé by John Tozzi. It's a really good article, and you'll see everything that we talk about today in writing with all the fact-checking that one would expect from Bloomberg News. So, okay … what we'll do in this episode is, first, we're gonna talk about the infusion nonmarket, the inches and its implications, such as an infusion costing 500 times Medicare when there are 1.5x Medicare options in the same exact health system. Sometimes I just can't even with some of this stuff. But another nonmarket tell, again, is that carrier networks are still in business. We talk all about that. What happens next in this episode is we deconstruct the roadmap that Ivana used to fight back, which starts with (no surprises) drilling into data and ends with direct contracting with independent doctors. And how that happens is by carving out utilization management so that there is site-of-care steerage. So, this is a conversation about fiduciary duty. It's a conversation about transparency, the power of collective action. This podcast is sponsored by Aventria Health Group with an assist from Payerset. And I thank Payerset very much for the financial support. Also mentioned in this episode are UNITE HERE HEALTH; Jacob Asher, MD; Keith Hartman, RPh; Stan Schwartz, MD; ZERO.health; John Tozzi; Aventria Health Group; Payerset; Cora Opsahl; 32BJ Union Health Fund; Jonathan Baran; Peter Hayes; Erik Davis; Autumn Yongchu; Brian Cotter; Bright Spot Insights; John Quinn; Mark Newman; Nomi Health; Preston Alexander; Health Here; Ann Lewandowski; HealthCheck360; Sam Flanders, MD; Shane Cerone; Kada Health; and Cristin Dickerson, MD. For a list of healthcare industry acronyms and terms that may be unfamiliar to you, click here.   You can learn more at uhh.org and by connecting with Ivana on LinkedIn.   Ivana Krajcinovic, PhD, recently retired as vice president for healthcare delivery at UNITE HERE HEALTH (UHH), a national Taft-Hartley Fund that purchases healthcare for over 200,000 unionized hospitality workers and their families. Combining her training as a health economist with more than 30 years working directly with immigrants and the working poor, Ivana oversaw a wide variety of projects. She has deep expertise in engaging participants, ranging from benefit education to chronic disease self-management, as well as in developing peer-to-peer programs. Ivana led a team whose challenge was to radically bend the cost curve while maintaining quality coverage as every dollar that UHH spends on healthcare is a dollar that could go to a worker in wages—higher wages that are likely to do more for workers' health than increasing spending on their healthcare. Ivana and her team have utilized narrow networks, value-based contracts, and direct contracting and have established health centers designed for their members. Ivana has a PhD in economics from Yale University and is the author of From Company Doctors to Managed Care: The United Mineworkers' Noble Experiment (Cornell University Press).   00:00 $135 vs $13,560: How infusion drug prices play into the "Inches All Around Us" series. 02:02 How infusion drug pricing fits into the "No Market" series. 03:19 A roadmap and more episodes on this topic. 04:36 Introducing this week's expert, Ivana Krajcinovic, PhD. 05:10 A must-read Bloomberg News article on infusion pricing. 05:33 An overview of what to expect from this episode. 06:54 The first tell of the infusion nonmarket. 07:41 The price variations that Ivana has seen in the infusion nonmarket. 11:39 How hospital spend affects wage increases affects patients and employees twice over. 12:04 EP373 with Cora Opsahl. 13:43 The second tell of the infusion nonmarket. 14:33 Take Two: EP398 with Jacob Asher, MD. 14:55 EP483 with Jonathan Baran. 16:15 Why networks are apathetic to this pricing discrepancy. 17:55 The factors that play into the nonmarket issue of infusion drug pricing variations. 18:26 EP475 with Peter Hayes. 19:18 EP370 with Erik Davis and Autumn Yongchu. 19:45 Are pricing discrepancies easy to spot? 22:38 Where we have power in a nonmarket situation. 23:22 A recap of the advice in the show so far. 23:39 EP493 with John Quinn. 23:41 EP496 with Mark Newman. 25:51 How you place pricing pressure on an entity. 28:47 EP482 with Preston Alexander. 29:34 How an improved market creates time for better care coordination. 30:52 EP486 with Stan Schwartz, MD. 33:23 The fourth part of the roadmap. 36:41 EP492 and EP490 with Sam Flanders, MD, and Shane Cerone. 36:49 Why serving the community and being fiscally responsible should go hand in hand. 38:05 EP500 with Stacey.   You can learn more at uhh.org and by connecting with Ivana on LinkedIn.   Ivana Krajcinovic, PhD, discusses #infusion #drugpricing on our #healthcarepodcast. #healthcare #podcast #financialhealth #commericalpayermarketplace #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Dr Jacob Asher (Take Two: EP398), Stacey Richter (EP500), Dr Jay Kimmel, Mark Noel, Gary Campbell (Take Two: EP341), Zack Kanter, Mark Newman, Stacey Richter (INBW45)

Chris and Hector break down a headline that made it sound like the FBI was running a dark web drug market and separate rumor from reality. They revisit how confidential sources actually work, the fallout from past undercover operations, and why media framing matters. The conversation then shifts to zero click exploits sold to foreign actors, the risks behind LinkedIn identity verification, and a security researcher who found a simple but devastating vulnerability only to be threatened by lawyers. Join our Patreon for weekly bonus episodes: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/c/hackerandthefed⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Send HATF your questions at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠questions@hackerandthefed.com

There were more than 70,000 cases of alleged drug use during pregnancy sent to law enforcement officials across 21 states over six years, including Oregon. As reported in The Marshall Project, these cases involved unreliable drug tests that show inaccurate results, are difficult to read or are simply wrong. In Oregon, and in 12 other states, welfare agencies automatically report any positive test result to authorities. Shoshana Walter is a staff writer for The Marshall Project and reported on this trend with Jill Castellano. Walter joins us to share more on these tests.

-Matt Welch's Caribbean identity crisis at Da Pig Beach-The State of the Union aka a two-hour hostage note-A greatest hits, lowest lights compilation for President Camacho-The futility of “speeching” your way through a math-defying approval rating-You can't talk your way through a 38% approval rating-Let the hockey boys drink-Dan Crenshaw is allowed to be mad-The RNC's new guard of real fucking bozos and sycophantic dick-tots-JD Vance as anti-corruption czar and populist beard for the crypto-regime-Tariffs and The Gilded Age corruption engine, now with “ballroom fund” exclusions-Drug prices are down 600%,….so do you owe me money?-Moynihan screaming drug questions at his glitching phone-Marxist Republicans and the gobbledygook of corporate housing bans-Maybe let's just abolish the State of the Union-Dispatches from the Purple State: An interview with Senator Elissa Slotkin-Stop kicking allies in the teeth to play grab-ass with dictators-Walking out on Lindsey Graham's Danish disdain-AI thinks Moynihan is a neo-folk neo-Nazi-Four years of war and Ukraine gets a one-sentence hand wave-Anthropic vs. Hegseth: Code is speech until the Pentagon wants a frictionless kill-switch-We tried collectivism once. Everyone starved. The end.-Gemini identifies the mystery caller as Friedrich Nietzsche, chimney sweep-About that BBC BAFTA N-Word Drama….-“You're acting like Israel” is the ultimate Park Slope breakup trump cardPrefer to watch & chat live with other members of the Fifdom? This episode premieres over on our YouTube channel NOW.The Fifth Column (A Podcast) is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber.Follow The Fifth ColumnYouTube: @wethefifthInstagram: @we.the.fifthX: @wethefifthTikTok: @wethefifthFacebook: @thefifthcolumn This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.wethefifth.com/subscribe

Christian Carmona grew up in Medellín's infamous Barrio Antioquia—an area known for prostitution, gambling, and later, cocaine. In this episode, Christian tells the inside story of a Colombian cocaine dynasty that quietly expanded from Medellín to Miami… and even Portland, Oregon. Raised “Americanized” in the suburbs, Christian didn't learn the truth about his father's criminal enterprise until federal agents came crashing down in 1991—taking both of his parents at once. From cartel-era Miami strategies (stash houses, mules, low-profile living) to family-wide trafficking ties and the chaos of the early 90s, Christian lays out how the business really worked behind the scenes. The story gets even wilder when Christian later gets pulled back into the orbit of his father's old associates—working at a bank where traffickers allegedly used safety deposit boxes to stash cash and kilos. A setup, a sting, and years of court delays later, Christian describes spending nearly four years incarcerated while prosecutors tried to force him to cooperate. This is a raw conversation about family, loyalty, survival, and redemption—plus how Christian found faith and wrote his book Zeal while locked up.

Follow Dave & Mahoney everywhere:Instagram: @daveandmahoneyTikTok: @daveandmahoneyFacebook: @daveandmahoneyYouTube: @daveandmahoneyAgree? Disagree? Want to yell at us?Voicemail: 833-YO-DUMMY Additional Content: daveandmahoney.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Nemesio Osegura Cervantes – known as 'El Mencho', head one the most important criminal organisations in Mexico, was killed by Mexican security forces on Sunday. Following his death, violence erupted across a number of Mexican states leading to the death of at least 74 people and over 9,500 troops have been deployed across the country in response to the violence. President Claudia Sheinbaum has said that normality has returned, but several foreign governments are still warning against travel to some states.Find a transcript and worksheet at: https://www.bbc.co.uk/learningenglish/english/features/learning-english-from-the-news_2026/260225Try Our World in English - BBC documentaries adapted in simple English: https://www.bbc.co.uk/learningenglish/english/features/our-world-in-englishFind out about our latest programmes. Subscribe to our email newsletter: https://www.bbc.co.uk/send/u178220599

The Hawks in KwaZulu-Natal have launched major raids on multiple drug dens across Chatsworth, south of Durban. Authorities say they've been closely monitoring these locations for nearly a year, targeting drugs linked to well-known syndicates under long-term investigation. One suspect has been arrested during the operation. Police say the crackdown aims to disrupt organised drug networks operating in the area. Sakina Kamwendo spoke to SABC reporter Jayed Paulse,

In this episode of the Joyful Health Show, I talk with registered dietician, nutritionist, and certified eating disorder specialist Liesel Maddox about GLP-1s. Are they a magic pill for weight loss, and what are the concerns around taking these medications? We are answering your questions, and as always, striving to bring you a grace-centered discussion on conversations that matter. We'll discuss: What are GLP-1s and how do they work? Can we safely use them to lose 10-15lbs? Can you take a GLP-1 indefinitely? We believe you are free in Christ to make informed decisions about your health. May this episode serve to give you more fuel for prayer as you consider the role of GLP-1s in your life. "For the kingdom of God is not a matter of eating and drinking but of righteousness and peace and joy in the Holy Spirit. Whoever thus serves Christ is acceptable to God and approved by men. So then let us pursue what makes for peace and for mutual upbuilding." Romans 14:17-19 Let's break it down: 05:51 What are GLP-1s?12:36 Side Effects and Malnutrition Risks16:50 Can Vitamins Replace Food20:21 Stopping the Drug and Regain32:10 Peptide Therapy Explained37:17 Christian Discernment Framework41:36 Healing Food Noise50:44 Prayer And Sendoff

Health Affairs' Rob Lott interviews So-Yeon Kang of Georgetown University about her recent paper exploring trends in biopharmaceutical clinical trials after The Inflation Reduction Act of 2022 authorized Medicare to negotiate prices for selected drugs. Order the January 2026 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast

Trigger Warning / Content Disclaimer This raw, true survivor story contains explicit details of heavy drug use, narcissistic abuse, physical violence, and attempted murder. Listener discretion is strongly advised. In this powerful episode of When Dating Hurts, we interview Abe, now 20 years old. Before diving in, we strongly recommend listening to episodes 310 and 311 where Abe's mother, Heather, shares her own harrowing story of serial narcissistic abuse, near-fatal domestic violence, and survival at the hands of her ex-husband Rick. Abe was also repeatedly emotionally and physically abused by Rick during those years. Abe bravely opens up about his experience starting at age seven and lasting until he was thirteen. He paints a vivid picture of daily abuse in a home where a child feels powerless — and reveals how his own actions played a key role in helping his mother survive. Heather and Rick were both deep in active addiction throughout this nightmare. While many assume drugs caused the abuse, Heather has always been clear: drugs do not cause narcissistic abuse or domestic violence — they make it far more dangerous and deadly. This episode drives that truth home through a child's eyes. In this episode you'll hear: • What it's really like growing up with narcissistic parents and early childhood trauma • A string of emotionally and physically abusive acts from a violent stepfather • How a young boy became an unlikely hero in his mother's fight to survive attempted murder • The brutal reality of drug addiction combined with intimate partner violence • A child's perspective on living in constant fear with no escape It is nothing short of a miracle that both Heather and Abe are alive today. If you or someone you love is trapped in narcissistic abuse, domestic violence, toxic relationships, or addiction-fueled trauma, this story delivers raw hope, validation, and proof that recovery and freedom are possible. Perfect for anyone searching: • Narcissistic abuse recovery stories • Domestic violence survivor interviews • Child survivors of narcissistic abuse • Escaping abusive relationships with children • Healing from narcissistic parents • Drug addiction and intimate partner violence • Real stories of surviving attempted murder

Trigger Warning / Content Disclaimer This raw, true survivor story contains explicit details of heavy drug use, narcissistic abuse, physical violence, and attempted murder. Listener discretion is strongly advised. In this powerful episode of When Dating Hurts, we interview Abe, now 20 years old. Before diving in, we strongly recommend listening to episodes 310 and 311 where Abe's mother, Heather, shares her own harrowing story of serial narcissistic abuse, near-fatal domestic violence, and survival at the hands of her ex-husband Rick. Abe was also repeatedly emotionally and physically abused by Rick during those years. Abe bravely opens up about his experience starting at age seven and lasting until he was thirteen. He paints a vivid picture of daily abuse in a home where a child feels powerless — and reveals how his own actions played a key role in helping his mother survive. Heather and Rick were both deep in active addiction throughout this nightmare. While many assume drugs caused the abuse, Heather has always been clear: drugs do not cause narcissistic abuse or domestic violence — they make it far more dangerous and deadly. This episode drives that truth home through a child's eyes. In this episode you'll hear: • What it's really like growing up with narcissistic parents and early childhood trauma • A string of emotionally and physically abusive acts from a violent stepfather • How a young boy became an unlikely hero in his mother's fight to survive attempted murder • The brutal reality of drug addiction combined with intimate partner violence • A child's perspective on living in constant fear with no escape It is nothing short of a miracle that both Heather and Abe are alive today. If you or someone you love is trapped in narcissistic abuse, domestic violence, toxic relationships, or addiction-fueled trauma, this story delivers raw hope, validation, and proof that recovery and freedom are possible. Perfect for anyone searching: • Narcissistic abuse recovery stories • Domestic violence survivor interviews • Child survivors of narcissistic abuse • Escaping abusive relationships with children • Healing from narcissistic parents • Drug addiction and intimate partner violence • Real stories of surviving attempted murder

Drug lord Nemesio Oseguera, known as “El Mencho,” was killed in a military raid in Mexico over the weekend. Laura Gottesdiener of Reuters explores how the operation went down. President Trump wasted no time imposing a new global tariff after the Supreme Court struck down his previous ones. Courtenay Brown of Axios joins to discuss what comes next for businesses and consumers. The Winter Olympics concluded Sunday night, and it was a pretty good showing for Team USA overall. The Athletic’s Matt Futterman explains how a series of injuries and other mishaps kept the Americans from a historic performance. Plus, authorities shot and killed a man after he breached the perimeter at President Trump’s Mar-a-Lago estate, New York braced for another big snowstorm, and how Punch the orphaned macaque captured the internet’s heart. Today’s episode was hosted by Yasmeen Kahn.

Stephen Parr, Meteorologist for "The Joe Piscopo Show" and co-host of "American Ground Radio" on AM 970 The AnswerTopic: Blizzard in New York City metropolitan area Lt. Col. David Sierotowicz (sir-ROW-tow-witz), Acting Superintendent of the New Jersey State Police and State Director of Emergency ManagementTopic: Conditions in New Jersey amid the blizzard Chris Swecker, attorney who served as assistant director of the FBI for the Criminal Investigative Division from 2004 to 2006 Topic: Armed man shot and killed at Mar-a-Lago; Drug lord El Mencho killed Christina Farrell, Commissioner of the NYC Office of Emergency Management Topic: Blizzard in New York City Jeff James, Retired Assistant Special Agent in Charge with the U.S. Secret ServiceTopic: Secret Service killed armed man at Mar-a-Lago Javier Lojan (Lo-HAHN), Acting Commissioner of the NYC Department of SanitationTopic: Snow clean-up in New York City Grover Norquist, President of Americans for Tax ReformTopic: Future of tariffs after SCOTUS ruling Col. Jack Jacobs, a retired colonel in the United States Army and a Medal of Honor recipient for his actions during the Vietnam WarTopic: U.S. military's involvement in death of El Mencho Christopher Hoenig, Spokesman for JCP<opic: Power outages Joseph diGenova, former U.S. Attorney for the District of ColumbiaTopic: SCOTUS ruling against Trump tariffs Sheriff Shaun Golden, Monmouth County SheriffTopic: Snow in New JerseySee omnystudio.com/listener for privacy information.

Dr. Kirsten Viola Harrison, trauma psychologist, author, and founder of Soul Wise Solutions, brings over 35 years of experience helping individuals navigate profound psychological and spiritual transitions. In this powerful podcast conversation, she shares her work with clients living with complex PTSD, dissociative identity disorder (DID), schizophrenia, trauma recovery, and near-death experiences, offering deep insights into healing, resilience, and spiritual integration in psychotherapy. Dr. Harrison is the co-author of I, Sean/a: The Story of a Homeless Intersex Woman Who Inspired a Community, the remarkable true story of Sean/a Smith — a homeless intersex woman living with schizophrenia whose life challenges stigma and inspires a movement toward dignity, inclusion, trauma healing, and community transformation. Her story powerfully addresses mental health stigma, homelessness, schizophrenia awareness, and intersex advocacy.

For the latest freelance journalist based in Mexico, Stephania Carpi, Correspondent for the Guardian Newspaper Rory Carroll and for the latest on travel distruptions Tom Randles, President of the Irish Travel Agents Association and Managing Director of Barter's Travelnet in Cork.

Gregory Zuckerman profiles Moderna CEO Stephane Bancel and the pivotal mRNA research by Kariko and Weissman, noting the company's difficult transition from drug therapies to vaccines. 2

In this jaw-dropping episode , we sit down with George Day — one of the most prolific yet largely unknown drug kingpins in American history. Raised in Washington, DC, George was literally born into the drug trade. By age six, he was traveling across the border with his father, helping smuggle hundreds of pounds of marijuana hidden inside a Winnebago. As he grew older, his life spiraled deeper into the underworld — from trimming weed in Mexico to handling massive cash pickups and negotiating with Colombian suppliers before he was even a teenager. After his father's sudden death, George found himself — at just 11 years old — sitting on a multimillion-dollar drug ledger, forced to navigate dangerous debts, cartel relationships, and violent street politics. What followed was the rise of a cocaine empire that eventually stretched across all 50 states… and ultimately led to a life sentence plus 90 years in federal prison. This is Part 1 of an unbelievable story about family, survival, crime, and the realities of growing up inside America's drug economy.

Timestamps00:06 - Live stream with Liz discussing her new stylish headphones.01:56 - YouTube's changing algorithms impact subscriber counts and content quality.05:49 - Quick diagnosis leads to unnecessary statin prescription without proper testing.07:52 - Pharmaceutical trust can lead to misunderstandings about health issues.11:31 - Discussion on creating alternative food resembling traditional dishes.13:35 - Struggling with diet consistency requires reliable fallback options.17:18 - Discussion on dragon fruit and its carbohydrate content in a carnivore diet.19:09 - Carnivore diet may reduce inflammation, but supplements can still be beneficial for some individuals.22:34 - Patient experiences unusual reactions related to amoxicillin and hearing loss.24:13 - Discussion on the complexities of steroid and antibiotic usage in medical treatment.27:44 - Recognizing the importance of mistakes for personal and professional growth.29:30 - Learning from dietary mistakes can improve future choices.32:34 - Carnivore diet simplifies meal preparation and reduces food-related stress.34:18 - Discussion on the impact of GLP1 drugs and faith in pharmaceutical practices.37:49 - Study lacks proof on patient leaflet reading impacting drug side effect claims.39:49 - Public awareness is challenging pharmaceutical industry's narrative.43:12 - Drug companies often underreport side effects of medications.45:08 - Tips for cooking and storing meats more effectively.48:38 - Concerns about cholesterol levels and CAC scores require more detailed health information.50:34 - Understanding baseline health metrics is crucial for interpreting dietary changes.53:53 - Contextual understanding is essential for evaluating health issues.55:52 - Food labelling often misleads consumers about ingredients.59:24 - Discussion on channel updates and audience engagement strategies.

News On he Flipside tonight tariffs in trouble Iran in trouble prince Andrew in trouble lots more news and lots of clips tonight . The moon is no longer silent – and something is waking up there US intercepts Russian spy plane over Alaska Simulated scenario of Iranian air defenses against bomber Iran has promised Trump its oil riches. It could be a clever ploy to avoid war Scientists say we may have been wrong about the origin of life Dark Eagle explained, America's new hypersonic missile built to strike 1,700+ miles with almost no warning “I mapped the invisible”: American high-school student stuns astronomers by discovering 1.5 million hidden cosmic objects The moon is no longer silent – and something is waking up there Putin's 'polonium assassin' makes chilling WW3 warning - 'bunkers won't save you' Five years on Mars: The rover's strangest finds so far Skull of 'dinosaur from hell' discovered with sword jutting from its head Drug cartel jet seized in jungle makes shocking takeoff caught on camera Something crossed our solar system – and we still don't know what it was Fresh WWIII fears as German army chief predicts Europe will suffer things we cannot even imagine at the hands of Putin The moon is no longer silent – and something is waking up there NASA report paints damning picture of Boeing mishap that stranded two astronauts in space Scientists warn mega-tsunami could wipe out US cities in minutes NASA satellite captures mysterious human voices echoing through space Secret CIA Files Claim Alien Presence on the Dark Side of the Moon — “They Told Us to…” The spy plane the US government says doesn't exist Inside the coming 7th generation fighter, hypersonic speed, space operations, AI decision-making, and the next air superiority arms race Seth Meyers predicted that Trump would announce alien life Acorn-shaped UFO crashes and soldiers seal Pennsylvania fores The F-47 explained, how Boeing's secret 6th gen fighter was flying since 2019 and why China fears it 2 billion years old – the nuclear reactor that shouldn't be there Roger Stone says Richard Nixon told comedian Jackie Gleason that UFOs are real and took him to a Florida military facility to show him alien life

This episode covers: • Microplastics Are Destroying Male Fertility and Metabolism New research is putting microplastics in a category most men still are not taking seriously: direct reproductive and hormone risk. A 2024 study detected microplastics in every human testicle examined, with polyethylene and PVC among the most common polymers. PVC is especially relevant because it's often tied to chemical additives that can disrupt endocrine signaling. The broader body of evidence points to micro- and nanoplastics crossing barriers like the blood–testis barrier, driving inflammation and oxidative stress in the testes, and showing associations with impaired sperm quality and hormone disruption. The longevity move here is reducing overall load: better water filtration, less plastic food contact, no heating food in plastic, fewer packaged foods, and taking indoor dust and air quality seriously, especially for men thinking about fertility now or hormone resilience over decades. • Sources: – Study (PubMed): https://pubmed.ncbi.nlm.nih.gov/38745431/ – Coverage: https://people.com/microplastics-in-every-human-testicle-infertility-8651215 • Fear of Aging Is Linked to Faster Biological Aging A new study ties aging anxiety to measurable acceleration in biological aging using DNA methylation clocks. People who reported more worry and negative beliefs about aging showed faster epigenetic aging signals, and the molecular differences clustered around stress and inflammatory pathways. In plain terms, chronic threat-mode thinking around aging maps onto biology that looks older on the clocks. For a longevity audience, this is a practical reminder that mental inputs affect physiological outputs. If your day-to-day mindset is constant pressure and decline narratives, that can show up downstream in stress biology and inflammatory tone. A smarter play is building a longevity framework around function, strength, purpose, and community, alongside the usual pillars like sleep, training, and metabolic health. • Source: https://medicalxpress.com/news/2026-02-older-links-health-faster-epigenetic.html • Additional source: https://www.nyu.edu/about/news-publications/news/2026/february/aging-anxiety.html • Retatrutide, the Triple-Agonist Weight-Loss Drug Pushing Bariatric-Level Results Retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors, and the weight-loss numbers being reported are massive. In a 68-week study in people with obesity and knee osteoarthritis, the highest dose group averaged about 28.7% body-weight loss, along with meaningful improvements in knee pain and function. This is the next phase of incretin medicine: multi-agonist drugs that can move body weight by a quarter or more. For biohackers, the performance and longevity angle is implementation: preserving lean mass through resistance training, hitting protein targets, monitoring micronutrients, and building a maintenance plan that doesn't collapse the moment the drug stops. The upside is cardiometabolic risk reduction at scale. The key is running it with structure. • Sources: – Eli Lilly release: https://investor.lilly.com/news-releases/news-release-details/lillys-triple-agonist-retatrutide-delivered-weight-loss-average – Coverage: https://nypost.com/2026/02/18/health/people-dropped-out-of-retatrutide-trial-for-losing-too-much-weight/ – Background: https://news.harvard.edu/gazette/story/2026/02/whats-next-for-glp-1s/ • AI Can Predict 130 Diseases From a Single Night of Sleep Stanford's SleepFM project shows how much long-horizon health information is encoded in sleep. Researchers trained a foundation model on roughly 585,000 hours of clinical polysomnography data from about 65,000 people. From a single night of sleep study signals, the model could estimate risk for 130 conditions, including dementia, heart attack, heart failure, chronic kidney disease, stroke, atrial fibrillation, and all-cause mortality, and it generalized across cohorts better than simple demographic baselines. The big implication is that sleep architecture and micro-patterns (stage distribution, fragmentation, breathing stability, micro-arousals) function like a dense biomarker stream for systemic aging and disease risk. Expect better sensors and more validated risk dashboards over time. Right now, this is another reason to treat sleep as a core diagnostic pillar, not just a recovery habit. • Sources: – Stanford Medicine: https://med.stanford.edu/news/all-news/2026/01/ai-sleep-disease.html – Paper (Nature Medicine): https://www.nature.com/articles/s41591-025-04133-4 • Living at High Altitude May Protect Against Diabetes by Turning Red Blood Cells Into Glucose Sinks For years, population data has suggested lower diabetes rates at higher elevations. New mechanistic work is pointing to a surprising driver: red blood cells changing how they handle glucose under low oxygen conditions. In hypoxia, red blood cells can behave like glucose sinks, pulling more sugar out of circulation and improving glucose tolerance, which may help explain the protective association seen at altitude. The downstream potential is a new class of altitude-mimetic approaches that target erythrocyte metabolism as a glucose lever, separate from appetite suppression or classic diabetes pathways. For biohackers, it expands the metabolic toolkit and reinforces that oxygen environment and blood physiology matter more than we've given them credit for. • Source: https://medicalxpress.com/news/2026-02-red-blood-cells-sugar-high.html • Dietary Supplement Regulatory Uniformity Act and the Future of Supplement Access A proposed bill is aiming to stop states from layering extra rules on dietary supplements beyond federal law, creating one national standard instead of a patchwork of state-by-state restrictions. Industry groups are supporting it as a way to reduce confusion and compliance chaos, especially as some states explore age limits or special labeling requirements for certain supplement categories. The strategic implication for biohackers is that regulation shapes access. Uniformity can stabilize availability, but it also raises the stakes of federal decisions on controversial ingredients. This is one of those policy stories that quietly determines what stays on shelves, what disappears, and how much innovation survives in the supplement space. • Sources: – NutritionInsight: https://www.nutritioninsight.com/news/npa-crn-supplements-us-fda-legislation.html – Congressional release: https://langworthy.house.gov/media/press-releases/congressman-langworthy-introduces-dietary-supplement-regulatory-uniformity-act – NutraIngredients: https://www.nutraingredients.com/Article/2026/02/05/new-bill-aims-to-end-state-supplement-regulations/ All source links are provided for direct access to the original reporting and research. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: microplastics male fertility, microplastics testosterone decline, blood–testis barrier toxins, endocrine disruption plastics, sperm count microplastics, epigenetic age acceleration, fear of aging methylation, biological aging mindset, stress inflammation aging, retatrutide triple agonist, GLP-1 GIP glucagon weight loss, incretin drugs obesity treatment, muscle preservation on GLP-1, SleepFM AI model, sleep disease prediction, polysomnography risk scoring, dementia risk sleep data, altitude diabetes protection, hypoxia glucose metabolism, red blood cells glucose uptake, altitude mimetic therapy, Dietary Supplement Regulatory Uniformity Act, supplement regulation federal preemption, FDA supplement policy, biohacking news longevity, metabolic health optimization Thank you to our sponsors! - HeartMath | Go to https://www.heartmath.com/dave to save 15% off. - BrainTap | Go to http://braintap.com/dave to get $100 off the BrainTap Power Bundle. Resources: • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 0:00 – Intro 0:19 – Story 1: Microplastics in Testicles 1:44 – Story 2: Fear of Aging Accelerates Aging 3:30 – Story 3: Retatrutide Weight Loss Drug 4:42 – Story 4: Sleep Predicts Disease Risk 6:34 – Story 5: High Altitude & Diabetes 7:57 – Story 6: Supplement Regulation Bill 9:16 – Weekly Summary 10:51 – Outro See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Super Bowl came and went and Housewives nationwide had a lot to say, including Jill Zarin and Taylor Armstrong. Andy Cohen urged fans to call E! to complain but, in a move no one saw coming, Jill was immediately terminated. Today, we break down the aftermath of Jill's termination, the larger ramifications, the backtracking by several of her ex RHONY colleagues and last, but not least, the future of the show. Amanda Frances is not leaving RHOBH, is looking forward to her upcoming WWHL appearance and is diligently preparing for the reunion which will be filmed in a mere few weeks. Last, but not least, Lynne Curtin's daughter Alexa, has surfaced revealing severe issues with drugs, homelessness loss of limbs and so much more.  @behindvelvetrope @davidyontef BONUS & AD FREE EPISODES Available at - www.patreon.com/behindthevelvetrope  BROUGHT TO YOU BY: CHEERS -CheersHealth.com (Get 20% Off A Way To Feel Better The Morning After A Few Drinks With Code Velvet ) COYUCHI - coyuchi.com/VELVETROPE (15% Off Your First Order Of The Most Comfortable Organic Sheets) MOOD - www.mood.com/velvet (20% Off With Code Velvet on Federally Legal THC Shipped Right To Your Door) ADVERTISING INQUIRIES - Please contact David@advertising-execs.com MERCH Available at - https://www.teepublic.com/stores/behind-the-velvet-rope?ref_id=13198 Learn more about your ad choices. Visit megaphone.fm/adchoices

Something dark is happening in America and almost no one is connecting the dots. From the rise of mass shootings to the explosion of antidepressant use, I break down what RFK Jr is uncovering about SSRIs, cultural confusion, and a spiritual fog settling over the West  . We also expose the media spin around trans violence, Europe's identity crisis, and why leaders like Marco Rubio are calling the West back to strength before it is too late.   Podcast Episode 2035: Explosive Study Links Mass Shootings to the Drug Industry Doping 20% of America | don't miss this! Listen to more episodes of the Lance Wallnau Show at lancewallnau.com/podcast

TW: there is a story about sexual assault of minors around the time stamp 14:10-21.    Our Feminist Buzzkill Lizz is solo this week, serving you a pod full of horror — but with that super sweet pro-abortion cherry on top! She brings you up to speed on the latest WTAF reports of the government rounding up pregnant migrant teens and shipping them to a Texas prison known for not providing adequate healthcare. Yes, you read that right. Add in increased cases of pregnancy criminalization and the Right's continued crusade against abortion pills out of Kentucky and Louisiana, and we're ready to just nope right the fuck off this planet.   GUEST ROLL CALL:   Becca Rea-Tucker, The Sweet Feminist, is here to chat about her new book, The Abortion Companion handbook and allllll things abortion! Pro-abortion cakes AND supporting abortion seekers? WHAT MORE COULD YOU ASK FOR?!   Times are heavy, but knowledge is power, y'all. We gotchu.    OPERATION SAVE ABORTION: You can still join the 10,000+ womb warriors fighting the patriarchy by clicking HERE to for past Operation Save Abortion trainings, your toolkit, marching orders, and more.   HOSTS: Lizz Winstead IG: @LizzWinstead Bluesky: @LizzWinstead.bsky.social Moji Alawode-El IG: @Mojilocks Bluesky: @Mojilocks.bsky.social SPECIAL GUESTS: Becca Rea-Tucker IG: @TheSweetFeminist Bluesky: @TheSweetFeminist.bsky.social   GUEST LINKS: BUY: Becca's handbook, “The Abortion Companion” The Abortion Companion Book Swap The Sweet Feminist Website Becca's Linktree BUY: Becca's Baking Book  SIGN UP: Becca's Substack AVOW Texas Expose Fake Clinics   NEWS DUMP: KY Couple Arrested, Charged With Reckless Homicide After Reporting Miscarriage Abortion Pills Would Be Classified as Controlled Substances Under New Bill Republican US Senators File Amicus Brief to Eliminate the Mailing of Chemical Abortion Drugs, Including Mifepristone Judge Rejects Anti-Abortion Center's Lawsuit Against Top Massachusetts Officials Trump Administration Is Sending Pregnant Migrant Girls to South Texas Shelter Flagged as Medically Inadequate AAF Breakdown on Pregnant Incarceration  AAF RESOURCE: Hypocrites Unmasked   EPISODE LINKS: BUY: Michael Shannon / Jason Narducy & Friends Lifes Poster TICKETS: Michael Shannon & Jason Narducy Tour ADOPT-A-CLINIC: Emma Goldman Clinic in Iowa City, IA  Operation Save Abortion Expose Fake Clinics BUY AAF MERCH! EMAIL your abobo questions to The Feminist Buzzkills AAF's Abortion-Themed Rage Playlist   FOLLOW US: Listen to us ~ FBK Podcast  Instagram ~ @AbortionFront Bluesky ~ @AbortionFront TikTok ~ @AbortionFront Facebook ~ @AbortionFront YouTube ~ @AbortionAccessFront   TALK TO THE CHARLEY BOT FOR ABOBO OPTIONS & RESOURCES HERE! PATREON HERE! Support our work, get exclusive merch and more!  DONATE TO AAF HERE! ACTIVIST CALENDAR HERE! VOLUNTEER WITH US HERE! ADOPT-A-CLINIC HERE! GET ABOBO PILLS FROM PLAN C PILLS HERE! When BS is poppin', we pop off! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss a series of US Food and Drug Administration proposals for user fee program changes that would advance President Trump's priorities and the concerns they raise (:31). They also consider the impact of the agency's decision to review Moderna's mRNA flu vaccine application shortly after refusing to file it and using accelerated approval for one of the proposed indications (8:37), as well as ideas for sponsors wondering if their development advice is still good (25:24). More On These Topics From The Pink Sheet US FDA Proposing White House-Aligned Policies For User Fee Agreements: https://insights.citeline.com/pink-sheet/pathways-and-standards/user-fees/us-fda-proposing-white-house-aligned-policies-for-user-fee-agreements-D5JWRDGLCFBT7CYT3FGK3JAZNI/ After Moderna Flu Vaccine, Is US FDA's Accelerated Approval A Pathway Or A Pressure Valve?: https://insights.citeline.com/pink-sheet/pathways-and-standards/review-pathways/after-moderna-flu-vaccine-is-us-fdas-accelerated-approval-a-pathway-or-a-pressure-valve-EWMFKFWO3BB3JA6CQHC4E3JWPA/ Moderna Flu Vaccine Debate Could Resolve With Postmarket Study, FDA's Makary Suggests: https://insights.citeline.com/pink-sheet/vaccines/moderna-flu-vaccine-debate-could-resolve-with-postmarket-study-makary-suggests-Y3R657N2JZABRGFOSKADM33YA4/ Horse Trading? Oz, Bourla Exchange MFN Codification, Vaccine Collaboration Requests: https://insights.citeline.com/pink-sheet/market-access/pricing-debate/horse-trading-oz-bourla-exchange-mfn-codification-vaccine-collaboration-requests-X6UDDVOSMRBSTO5WC224IN6PTE/

IEEPA tariffs are found Unconstitutional, Learning Resources, Inc. v. Trump (2026).Today, Feb 20, 2026, the U.S. Supreme Court ruled in two combined cases that the International Emergency Economic Powers Act (IEEPA) does not give the President the power to impose tariffs on imports. This decision stopped tariffs set by President Trump to fight drug trafficking and trade deficits.Soon after becoming president, Trump declared national emergencies under IEEPA. He cited two big threats: Drug influx & Trade deficits.Businesses and states sued, saying IEEPA doesn't allow tariffs. One case started in a D.C. district court, which blocked the tariffs temporarily. The other went to the Court of International Trade (CIT) and was upheld by the Federal Circuit appeals court. They said IEEPA's words about "regulating importation" don't cover unlimited tariffs. The Constitution gives Congress, not the President, the power to set taxes and duties, including tariffs (Article I, Section 8). The Framers wanted Congress to control "the pockets of the people." Presidents have no natural right to impose tariffs in peacetime. The government argued IEEPA lets the President "regulate... importation," which they said includes tariffs of any size, length, or scope. But the Court disagreed, using these key points:Major Questions Doctrine: The Court is wary of laws that vaguely give away huge powers. Tariffs affect the economy massively, trillions in trade and billions in revenue. Congress wouldn't hide such a big handover in unclear words. In 50 years of IEEPA, no president had used it for tariffs. Past laws delegating tariff power were always clear and limited. This claim was too extreme, especially for the "power of the purse."Word Meanings in IEEPA: The law lists powers like "investigate, block, regulate, direct, nullify" imports or exports. It doesn't mention tariffs or duties. "Regulate" usually means to control or restrict, not to tax. Taxes are separate, Congress always says so explicitly when giving tax powers. If "regulate" included taxes, it might violate the Constitution's ban on export taxes. The other words in the list are about sanctions or controls, not raising money.No Exceptions: Even in emergencies or foreign affairs, Congress must clearly say if it's giving away tariff power. Tariffs aren't just regulation; they're taxes with big economic and political effects.The Court vacated (canceled) the D.C. case for jurisdictional reasons and affirmed (upheld) the Federal Circuit's ruling. IEEPA can't be used for tariffs. This protects Congress's role in trade policy.The opinion was written by Chief Justice Roberts, with parts joined by Justices Gorsuch and Barrett. It stresses separation of powers and careful reading of laws.This program is brought to you by DAT Freight & Analytics. Since 1978, DAT has helped truckers & brokers discover more available loads. Whether you're heading home or looking for your next adventure, DAT is building the most trusted marketplace in freight. New users of DAT can save 10% off for the first 12 months by following the link below. Built on the latest technology, DAT One gives you control over every aspect of moving freight, so that you can run your business with speed & efficiency. This program is also brought to you by our newest sponsor, GenLogs. GenLogs is setting a new standard of care for freight intelligence. Book your demo for GenLogs today at www.genlogs.io today!

In this powerful episode of "The Summer of Me," we explore the intricate process of how to get over a breakup . It's often not the person we miss, but the identity and personal growth, and opportunities we experienced within that relationship. Drawing on her personal experiences after divorce, she explains how fantasy, hope, and a focus on potential can keep someone attached to unhealthy dynamics. This discussion offers essential breakup advice, guiding you through the grieving process towards significant personal growth and self development. TIMESTAMPS: 00:00 Introduction 00:29 My Post-Divorce Relationship 01:22 Dating Potential 02:54 Hope as a Drug 05:13 Why Breakups Hurt 07:12 Identity After a Breakup 08:00 The Breakup Reframe 09:32 How to 'Metabolize the Grief' (Step-by-Step) 10:53 Rebuild Self-Expansion 12:26 Takeaways + Homework 14:18 Closing: You Were Always the Magic LINKS: Follow Kendra on Instagram: https://www.instagram.com/kendrafornow/ Subscribe on YouTube: https://www.youtube.com/@SummerofMe Produced by SocialPodcast.co

“That's the thing that's maybe getting lost in some of the fear mongering around it is that, it's not the easy way out. It doesn't mean that you don't have to do the work. It means that when you do the work, the work actually makes the difference.” —Aja BeckettFood noise can sit in the back of the mind all day, from planning the next meal at breakfast to carrying quiet shame after every snack. In a culture that moralizes weight and labels bodies as failures, real medical treatment for obesity often gets buried under hot takes about shortcuts and cheating. This conversation brings the lived reality of GLP-1 medication into the light, with honesty about both relief and responsibility.Aja Beckett shares decades of struggling with obesity, endless diets, and that constant mental hum around food, then walks through how starting a GLP-1 weight loss drug shifted cravings, energy, and hope. Her experience led to building Shotsy, a companion app that tracks doses, side effects, and progress for people on GLP-1 medications.Press play to hear how this new class of medications is reshaping daily life, mindset, and digital tools around obesity care, including:What GLP-1 drugs like Ozempic and Wegovy actually do in the bodyThe difference between “food noise” and genuine hungerWhy weight loss drugs are not a lazy shortcut or moral failureHow mental health, cravings, and compulsive behaviors often change on GLP-1sThe cost, access, and safety concerns around weight loss injections and pillsHow a GLP-1 tracking app grew from one person's spreadsheet into a fast-growing productWhat long-term obesity treatment and maintenance can realistically look likeConnect with Heather:WebsiteLinkedInInstagramFacebookYouTubeEpisode Highlights:01:11 Meet Aja Beckett: Founder of Shotsy & GLP‑1 Success Story04:43 Discovering Ozempic & a Difficult Doctor's Visit07:35 Beyond Weight Loss: GLP‑1, Mental Health & Addictive Behaviors10:43 Losing 90 Pounds: From Obesity to Healthy BMI13:30 Do You Still Have to Eat Healthy & Work Out on GLP‑1?16:21 When the Food Noise Stops: First Days on GLP‑119:37 Super Bowl Snacks, Portion Control & Balanced Indulgence22:12 Body Dysmorphia in Bigger & Smaller Bodies26:00 Safety vs Affordability: Regulation, Shortages & DIY Risks32:09 Introducing Shotsy: The GLP‑1 Companion App Idea39:50 Why Tools Like Shotsy Matter for Accountability & Tracking42:21 GLP‑1 Isn't the “Easy Way Out”: Doing the Work & Seeing ResultsResources:

Long considered a transit route, Pakistan is now emerging as a major hub for both drug production and consumption. This shift follows the upheaval triggered by the Taliban's return to power in Afghanistan in 2021.

This episode explores tadalafil (Cialis) as a potential longevity drug, though no randomized human trials prove it extends lifespan. Cialis works by blocking PDE5, enhancing nitric oxide signaling, and improving blood flow through vasodilation. Originally approved for pulmonary hypertension, it's also used for erectile dysfunction and BPH. Its 36-hour half-life makes it superior to Viagra for continuous longevity effects.   The host frames vascular aging and endothelial dysfunction as key drivers of age-related diseases (heart disease, stroke, dementia, kidney disease). Observational data shows Cialis users have 44% lower mortality, fewer cardiovascular events, reduced dementia risk, and lower mortality in diabetics. Additional benefits include improved cardiac function, reduced infarct size, arrhythmia suppression, and regression of left ventricular hypertrophy. A 2024 meta-analysis found it lowers hemoglobin A1C, possibly via improved microvascular perfusion, insulin sensitivity, and mitochondrial function.   Cialis crosses the blood-brain barrier and may improve neurovascular coupling and hippocampal plasticity, potentially benefiting those with or at risk of dementia. Safety is generally good with long-term daily use (2.5–5 mg), though cautions include avoiding use with nitrates, low blood pressure, or certain retinal disorders. Common side effects are headache, nasal congestion, and acid reflux. The host recommends consulting a doctor and references potential synergy with telmisartan.   Tadalafil (Cialis) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a604008.html](https://medlineplus.gov/druginfo/meds/a604008.html) Sildenafil (Viagra) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a699015.html](https://medlineplus.gov/druginfo/meds/a699015.html)   Key mechanisms mentioned Nitric Oxide (NO) — NCBI Bookshelf: [https://www.ncbi.nlm.nih.gov/books/NBK554485/](https://www.ncbi.nlm.nih.gov/books/NBK554485/) Cyclic GMP (cGMP) — NCBI Bookshelf: [https://www.ncbi.nlm.nih.gov/books/NBK542234/](https://www.ncbi.nlm.nih.gov/books/NBK542234/)   Conditions mentioned in the episode Benign Prostatic Hyperplasia (BPH) — MedlinePlus: [https://medlineplus.gov/benignprostatichyperplasia.html](https://medlineplus.gov/benignprostatichyperplasia.html) Pulmonary Arterial Hypertension (PAH) — MedlinePlus: [https://medlineplus.gov/pulmonaryhypertension.html](https://medlineplus.gov/pulmonaryhypertension.html)   Blood pressure drug mentioned Telmisartan — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a601249.html](https://medlineplus.gov/druginfo/meds/a601249.html)   Other longevity / comparison drugs mentioned Metformin — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a696005.html](https://medlineplus.gov/druginfo/meds/a696005.html) Sirolimus (Rapamycin) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a602026.html](https://medlineplus.gov/druginfo/meds/a602026.html)   Side-effect helper mentioned Ibuprofen (Advil) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a682159.html](https://medlineplus.gov/druginfo/meds/a682159.html)   Dementia meds mentioned Donepezil (Aricept) — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a697032.html](https://medlineplus.gov/druginfo/meds/a697032.html) Amantadine — MedlinePlus drug info: [https://medlineplus.gov/druginfo/meds/a682064.html](https://medlineplus.gov/druginfo/meds/a682064.html)   Lab markers mentioned Hemoglobin A1C (HbA1c) test — MedlinePlus lab test: [https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/](https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/) Insulin in blood test — MedlinePlus lab test: [https://medlineplus.gov/lab-tests/insulin-in-blood/](https://medlineplus.gov/lab-tests/insulin-in-blood/)   People referenced (where the claims were mentioned) Huberman Lab (Dr. Andrew Huberman) — site: [https://www.hubermanlab.com/](https://www.hubermanlab.com/) Clip about low-dose tadalafil (2.5–5mg) — X post: [https://x.com/tbpn/status/2022350426394534334](https://x.com/tbpn/status/2022350426394534334) Bryan Johnson (Blueprint) — site: [https://blueprint.bryanjohnson.com/](https://blueprint.bryanjohnson.com/) Dr. David Sinclair (Harvard profile) — site: [https://sinclair.hms.harvard.edu/people/david-sinclair](https://sinclair.hms.harvard.edu/people/david-sinclair)   Show Notes   00:00 Welcome to the Hart2Heart Podcast. 01:56 What Cialis Is: PDE5 Inhibition, cGMP & Nitric Oxide Explained 03:43 Approved Uses & Origin Story: Pulmonary Hypertension, ED, and BPH 05:33 Why Cialis Over Viagra: 36-Hour Half-Life & 24/7 Vascular Benefits 06:52 Vascular Aging 101: Endothelium, Perfusion, and Why It Drives Disease 11:14 What the Human Data Shows: Observational Evidence for Mortality, CVD & Dementia 13:04 Mechanisms Deep Dive: Heart Protection, Heart Failure, and Anti-Atherosclerosis 15:02 Cialis for Diabetics: Lowering A1C and Improving Insulin Sensitivity 16:21 Brain Effects: Blood–Brain Barrier, Neurovascular Coupling & Dementia Potential 18:21 Safety, Who Should Avoid It, and Daily Longevity Dosing (2.5–5 mg) + Wrap-Up   The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to cutting through the noise and uncovering the most effective strategies for optimizing health, longevity, and peak performance. This podcast dives deep into evidence-based approaches to hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise protocols, leveraging sunlight, and de-prescribing pharmaceuticals — using medications only when absolutely necessary. Beyond health science, we explore the intersection of public health and politics, exposing how policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being. Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen). If you're ready to take control of your health and performance, this podcast is for you.We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect with Dr. Mike Hart Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart

SWAT Team STORMS Court Mid Game After Paul George's Drug Confession NBA Suspended

Aubrey Masango speaks to Chad Thomas, Crime Expert at IRS Forensic Investigations to discuss the phenomenon of murder-for-hire in South Africa, examining the circumstances surrounding Phenya's tragic death and exploring the disturbing trends that point to a growing epidemic of contract killings. Tags: 702, Aubrey Masango show, Aubrey Masango, Bra Aubrey, Chad Thomas, Murder-for-hire, Marumo Phenya, Whistleblower, PKTT, Drug cartel, Gang violence, Inkabi The Aubrey Masango Show is presented by late night radio broadcaster Aubrey Masango. Aubrey hosts in-depth interviews on controversial political issues and chats to experts offering life advice and guidance in areas of psychology, personal finance and more. All Aubrey’s interviews are podcasted for you to catch-up and listen. Thank you for listening to this podcast from The Aubrey Masango Show. Listen live on weekdays between 20:00 and 24:00 (SA Time) to The Aubrey Masango Show broadcast on 702 https://buff.ly/gk3y0Kj and on CapeTalk between 20:00 and 21:00 (SA Time) https://buff.ly/NnFM3Nk Find out more about the show here https://buff.ly/lzyKCv0 and get all the catch-up podcasts https://buff.ly/rT6znsn Subscribe to the 702 and CapeTalk Daily and Weekly Newsletters https://buff.ly/v5mfet Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

In this bonus episode of Medication Talk, join us as we revisit our Notable New Meds of 2025 webinar and highlight two medications that didn't make it into the main podcast—both newly approved antibiotics with important implications for clinical practice.Listen in as our editors take a deeper look at:Gepotidacin (Blujepa) for uncomplicated urinary tract infectionsAztreonam/avibactam (Emblaveo) for complicated intraabdominal‑abdominal infectionsYou'll hear practical insights into where these therapies fit in current treatment approaches, what safety and interaction issues to watch for, and why they matter when resistance limits your options—giving you more confidence when either of these new meds show up in your practice.**No CE Credit is available for this bonus episode.**Use code mt1026 at checkout for 10% off a new or upgraded subscription.******TRC Healthcare Editors: Sara Klockars, PharmD, BCPSStephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC None of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in December 2025. The clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Chart: Urinary Tract InfectionsChart: Aztreonam-avibactam (Emblaveo)Article: Keep Boosting Antibiotic Stewardship for Complicated UTIsSend a text*****

Detectives Benson and Stabler are called in when an infant dies after drinking baby formula mixed with cocaine. When more tainted formula is found in the home of Derek Pfeiffer, Fin and Munch suspect he's been smuggling in the liquid coke from Mexico. But things take a turn when IAB takes over the investigation and Pfeiffer is murdered. Cragen strong-arms Tucker to let Elliot go undercover and infiltrate the drug ring. It's managed by a dirty cop, and when a sting goes sideways, Stabler is forced to shoot him in self-defense.  Still looking for the kingpin, Benson and Cragen learn Pfeiffer never had a baby. His wife had been taking her infant nephew to Mexico as a cover to smuggle the formula.  Now the kingpin is tying up loose ends by killing Mrs. Pfeiffer and all the other mothers who rented their babies as drug mules.We're talking about Special Victims Unit season 4 episode 12 "Risk." Our guest is Mel Barrett from the "Something's Off" and "The Inbetween" podcasts.Some inspiration for this episode comes from the 1992 case of NYPD officer Michael Dowd. For exclusive content from Kevin and Rebecca, sign up on Patreon.This show was recorded in The Caitlin Rogers Project Studio. Click to find out more. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

California voters were promised $370 million in cannabis tax revenue for drug prevention and youth treatment through Prop 64. So why are tens, even hundreds of millions flowing through activist nonprofits and voter registration efforts instead? In this episode, we break down what Prop 64 promised… where the money is actually going… and why many critics say “drug prevention” has turned into a political slush fund wrapped in good intentions. We unpack: How cannabis tax dollars are allocated The role of The Center at Sierra Health Foundation's Elevate Youth program Why NGOs tied to political organizing are receiving prevention funds What this says about accountability, governance, and cultural leadership And most importantly, what this means for men who choose to live clear-headed, sober-minded, and awake. Because sobriety isn't just about quitting alcohol.It's about discernment.It's about responsibility.It's about seeing straight in a culture that profits off distraction. Join the Victory Circle our free digital men's community and surround yourself with high-performing men living alcohol-free. Sober minds see straight… and straight calls make change. Sober Executive Performance Reset: A 12 Week Private Coaching Experience - APPLY HERE https://www.thatsoberguy.com/coaching Invite Shane to Speak - https://www.thatsoberguy.com/speaking Join “The Victory Circle”, our FREE Sober Guy Mens Community at https://www.thatsoberguy.com/offers/SvjjuEQ2/checkout Check out Shanes New Book, Sober Guy How Do I - https://a.co/d/81ZIgtE Tired of Drinking? Try Our 30 Day Quit Drinking Dude Challenge! - https://www.thatsoberguy.com/quit-drinking-alcohol-for-30-days For More Resources go to http://www.ThatSoberGuy.com Follow us on LinkedIn - https://www.linkedin.com/in/shane-ramer-7534bb257/ Follow us on Instagram @ThatSoberGuyPodcast Follow us on YouTube - https://www.youtube.com/thatsoberguypodcast  Follow us on X @ThatSoberGuyPod https://caldoge.rhetor.ai/prop-64 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The U.S. military conducted airstrikes on three alleged narco-trafficking boats, resulting in the deaths of 11 male narco-terrorists.See omnystudio.com/listener for privacy information.

WMAL GUEST: SARA CARTER (Director of the Office of National Drug Control Policy) on hosting a White House roundtable with social media companies to combat illicit drug sales targeting children. WEBSITE: ONDCP Official Page SOCIAL MEDIA: X.com/SaraCarterDC READ: Sara Carter Confirmed as National Drug Czar Where to find more about WMAL's morning show: Follow Podcasts on Apple Podcasts, Audible, and Spotify Follow WMAL's "O'Connor and Company" on X: @WMALDC, @LarryOConnor, @JGunlock, @PatricePinkfile, and @HeatherHunterDC Facebook: WMALDC and Larry O'Connor Instagram: WMALDC Website: WMAL.com/OConnor-Company Episode: Wednesday, February 18, 2026 / 8 AM HourSee omnystudio.com/listener for privacy information.

In the 8 AM Hour: Larry O’Connor and Bethany Mandel discussed: WMAL GUEST 8:05 AM - INTERVIEW - SARA CARTER - Director of the Office of National Drug Control Policy SOCIAL MEDIA: https://x.com/SaraCarterDC TOPIC: ROUNDTABLE TODAY AT WHITE HOUSE: Drug Czar Hosts Roundtable Discussion at the White House About Combatting Illicit Drug Trafficking on Social Media Bethany makes a good case for why the Weight loss drug hype is not a bad thing Meet Eileen Gu, an American competing for China at Winter Olympics CRITTER NEWS: Dog on the course at Olympic skiing event Where to find more about WMAL's morning show: Follow the Show Podcasts on Apple podcasts, Audible and Spotify. Follow WMAL's "O'Connor and Company" on X: @WMALDC, @LarryOConnor, @Jgunlock, @patricepinkfile, @bethanyshondark and @heatherhunterdc. Facebook: WMALDC and Larry O'Connor Instagram: WMALDC Show Website: https://www.wmal.com/oconnor-company/ How to listen live weekdays from 5 to 9 AM: https://www.wmal.com/listenlive/ Episode: Wednesday, February 18, 2026 / 8 AM Hour See omnystudio.com/listener for privacy information.

County alleges unlawful price inflation.

See Adam on tour https://theadamfriedland.show/pages/tour -- JOIN THE FRIEDLAND FAMILY FOUNDATION / PREMIUM SUBSCRIPTION: https://www.youtube.com/@TheAdamFriedlandShow/join -- Patreon: https://www.patreon.com/cw/TheAdamFriedlandShow -- Buy our merch!: https://theadamfriedland.show/collections/new -- The Adam Friedland Show - Season Two Episode 35 | Clavicular X: https://x.com/adam_talkshow Instagram: https://www.instagram.com/theadamfriedlandshow TikTok: https://www.tiktok.com/@adamfriedlandshowclips YouTube: Subscribe to @TheAdamFriedlandShow here: https://www.youtube.com/c/TheAdamFriedlandShow Subscribe to @TAFSClips here: https://www.youtube.com/@tafsclips -- Go to TempoMeals.com/TAFS to get 60% off your first box Head to livemomentous.com and use promo code TAFS for up to 35% off your first order — #adamfriedland #theadamfriedlandshow #Clavicular

In this episode of The Performance Medicine Show, Dr. Rogers answers YOUR health and wellness questions! Check out our online vitamin store:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠https://performancemedicine.net/shop/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for our weekly newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://performancemedicine.net/doctors-note-sign-up/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

This episode is a conversation with John Walsh, WOLA's director for Drug Policy and the Andes, about the ongoing U.S. military attacks on civilian boats in the Caribbean and Pacific Oceans. When Walsh and host Adam Isacson recorded this episode, on February 13, 2026, 35 attacks had killed at least 131 people since September 2, 2025—an average of four killings every five days—and another attack later that day killed 3 more people. Walsh and Isacson just published a WOLA commentary, "The Boat Strikes are Still Happening: Five Things You Need to Know," warning against the dangerous normalization of extrajudicial executions carried out directly by the U.S. military. Five months into this campaign, the strikes are fading from public attention despite their illegality. Media coverage has dwindled from the intense scrutiny of September and the revelations about "double tap" strikes on survivors in December to a trickle of stories. This normalization poses dangers: the justifications being used could extend to other victims in other contexts, and elements of the U.S. military appear to be accepting unlawful orders. There is no congressional authorization for military force against drug traffickers. Under international law, the United States is not engaged in an armed conflict with drug cartels—designating groups as foreign terrorist organizations does not confer wartime authorities. From a drug policy perspective, Walsh argues these strikes are futile. After five months, there is no evidence of a disruption to cocaine supplies. Drug trafficking organizations are highly adaptive, with alternative routes readily available. The administration's own recognition that traditional interdiction didn't work led them to this extreme escalation, but killing traffickers at sea will not fundamentally alter market dynamics driven by constant demand and enormous profits under prohibition. The boat strikes, if "normalized," could prepare the ground for grave future outcomes. The administration's willingness to label anonymous victims as "narcoterrorists" creates a template for applying similar labels to domestic opponents—something already visible in the characterization of ICE critics and the victims of Chicago and Minneapolis shootings as "domestic terrorists." Walsh notes that President Trump has expressed his desire to deploy military forces against "the enemy within" on U.S. streets, and the compliance of Southern Command with these illegal orders suggests obedience to the president over the Constitution. "The illegality is not a bug, it's a feature," Walsh concludes. Walsh concludes by emphasizing the importance of litigation on behalf of victims' families, the moral voice of faith leaders, and continued media attention to prevent normalization. These strikes, he argues, are not a peripheral story but central to the administration's declared strategy of dominating the Western Hemisphere through coercion.

These are some truly harrowing stories from legal substances that are even sold in gas stations! A big thank you to Someone That's NoOne for lending his voice for a few stories. Be sure to check his channel out!

In this week's Stansberry Investor Hour, Dan and John Engel welcome Dave Lashmet to the show. Dave is the editor of Stansberry Venture Technology, an advisory that takes a "venture capitalist" look at the market. Dave scours the market looking for little-known small-cap companies that are potentially producing the next wonder drug or technology.   Dave kicks things off by discussing the first of three biopharmaceutical companies he's sharing that have monopolies in weight-loss drugs. He starts by showing how drugs gain their monopolies via patents, giving them "economic exclusivity." While companies might be targeting the same patients, the patents influence how they're being treated. The first company gains an edge by not only targeting folks suffering from obesity, but also by treating those with Type 2 diabetes. Dave also explains the contrast in mentality between the U.S. and other countries regarding obesity being preventable. And he provides info showing how obesity is a "slippery slope" and shares that a study found that participants who got off the drug gained back the weight they lost before. (0:00)   Next, Dave sums up how the first company has cleared all of the risks and expenses from clinical trials, while a close competitor still has to get past its trials due to unknown side effects. When asked about why folks would stay on a weight-loss pill for life, Dave points to how our culture has drastically changed over the years, from actively working on farms to passively working in cubicles. These drugs help balance out the resulting shift. Dave then transitions into the next company that has a drug that focuses on fatty liver disease. He explains how this distinction helps the company gain its monopoly due to how irreplaceable livers are. And similar to the first company, this drug will have lifelong consumers. And the good news for investors is that its only competitor causes weight gain. (21:49)   Finally, Dave presents the final company that tackles weight loss by focusing on genetics. Unlike the first two companies, this one treats patients with an injectable drug rather than a pill. However, it zeroes in on our natural "hunger switch," suppressing the users' appetites. Right now, the company is only waiting to get past trials, which puts it at a disadvantage compared with the other two. But Dave still believes that because of how it works, it's still set to stand beside the two pills. (39:44)

See omnystudio.com/listener for privacy information.

The science says no, at least not in the athletic sense. But the psychic benefits can be large — just ask former N.F.L. star Ricky Williams. He says athletes should consider cannabis a healing drug, not a party drug. Even the N.F.L. is starting to agree. (Part two of a two-part series.) SOURCES:Angela Bryan, professor, associate chair for faculty development in the department of psychology and neuroscience at the University of Colorado, Boulder.Ricky Williams, former N.F.L. running back, founder of Highsman. RESOURCES:"Using A Lab On Wheels To Study Weed From Dispensaries," by Science Friday (2024)."Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans," by Michael Siebers, Sarah Biedermann, Laura Bindila, Beat Lutz, and Johannes Fuss (Psychoneuroendocrinology, 2021)."Endocannabinoids mediate runner's high," by Sudhakaran Prabakaran (Science Signaling, 2015)."Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions," by Angela Bryan, Arielle Gilman, and Kent Hutchison (Sports Medicine, 2015).Run Ricky Run, documentary (2010). EXTRAS:"Is America Switching from Booze to Weed?" series by Freakonomics Radio (2024). Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.